Now accepting Video or Phone Consultations. Schedule a virtual visit.

Research and Grants


Research Activities / Industrial Grants

  • A Multicenter, Randomized, Parallel Group, Double-Blind, Placebo Controlled, Flexible Dose Escalation Study to Evaluate Self-Esteem and Overall Relationships in Men with Erectile Dysfunction Treated with Viagra (Sildenafil Citrate) in the United States.
    Pfizer - Investigator Meeting: April 2001
  • A Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of IC351(LY450190) Administered “On Demand” to Patients with Erectile Dysfunction.
    Lily-ICOS  - Starting Date: 2000
  • A Randomized, Double-Blind Study (With Open Label Treatment Extension) to Evaluate the Efficacy and Safety of Viagra (Sildenafil) in Men with Symptoms of Depression and Erectile Dysfunction.
    Pfizer - Starting Date: September 1997
  • An Open, Non-Comparative Extension Study of Sildenafil in Patients with Erectile Dysfunction
    Pfizer - Starting Date: August 1977
  • An Open, Non-Comparative Study to Assess the Long-Term Safety of Sildenafil in Patients with Erectile Dysfunction.
    Pfizer - Starting Date: August 1996
  • Multi-Center Prospective cohort Study to Evaluate the Safety and Effectiveness of The American Medical Systems (AMS) Ambicor Inflatable Penile Prosthesis. American Medical Systems, Inc.
    Pfizer Hospital Products Group - Starting Date: 1996
  • A Double-Blind, Randomized, Placebo-Controlled Parallel Group, Fixed-Dose, Multi-Center Study to Assess the Efficacy and Safety of UK-92, 480, Administered Over Six Months to Male Patients with Erectile Dysfunction.
    Pfizer - Starting Date: February 1996
  • Long-Term Evaluation of the Safety and Efficacy of Alprostadil Administered by MUSE.
    Vivus - Starting Date: 1995
  • A Placebo-Controlled Safety and Efficacy Study of Alprostadil Alphadex (PGE 1-Cyclodetrin) in the Treatment of Erectile Dysfunction in Diabetic and Non-Diabetic Patients Followed by 48 Weeks of Open Label Treatment.
    Schwarz Pharma - Starting Date: October 1993
  • Treatment of Erectile Failure with Medicated Urethral System for Erection (MUSE).
    Vivus - June 1993 to Present
  • Pilot Study with Alprostadil Sterile Powder (PGE 1) in Erectile Dysfunction. Protocol M/56FP50/0074
    Upjohn - 1992 to May 1993
  • No Effect & Lowest Effective Dose-Finding Study of Alprostdil Sterile Powder (PGE1 in Erectile Dysfunction. Protocol M/56FP50/0080
    Upjohn - January 1993 to April 1993.
  • Long-Term Safety Study of Alprostdil Sterile Powder (PGE 1 Alprostadile Sterile Powder in Patients with Erectile Dysfunction. Protocol M/5650/0070
    Upjohn - Starting Date November 1992- present


J. Francois Eid, MD, receives or has received research support/grants from Coloplast Corporation, American Medical Systems (AMS), Lilly ICOS LLC Bayer, Vivus, Pharmacia-Upjohn and Pfizer Inc. He is/was a consultant and on the speakers bureau for Coloplast, AMS, Lilly ICOS LLC, Bayer and Pfizer Inc.

Advanced Urological Care PC
435 East 63rd Street
Upper East Side

New York, NY 10065
Phone: 212-535-6690
Fax: 212-535-7025
Office Hours

Get in touch